       Document 0627
 DOCN  M9440627
 TI    Guidelines for designing rapid assessment surveys of HIV seroprevalence
       among hospitalized patients. Centers for Disease Control and Prevention.
 DT    9404
 AU    Schwartlander B; Janssen RS; Satten GA; Critchley SE; Petersen LR;
       Dondero TJ; Centers for Disease Control and Prevention, Atlanta, GA
       30333.
 SO    Public Health Rep. 1994 Jan-Feb;109(1):53-9. Unique Identifier :
       AIDSLINE MED/94134917
 AB    The Centers for Disease Control and Prevention has developed guidelines
       for determining HIV seroprevalence among patients seeking medical care
       at acute-care hospitals. The guidelines enable hospital staff members to
       perform a simple, rapid, and inexpensive survey to determine
       seroprevalence among the patient population, protecting the anonymity of
       those who are tested. The guidelines are based on national experience
       with large-scale anonymous, unlinked HIV serosurveys. The data from a
       rapid assessment survey are particularly useful for evaluating the need
       to provide routine, voluntary HIV counseling and testing and treatment
       for HIV infection. Beyond that, such data can be used in targeting
       education efforts, in reinforcing the use of appropriate universal
       precautions, in resource allocation, and in determining the need for
       further studies of HIV infection among the population in the hospital
       catchment area.
 DE    AIDS Serodiagnosis/*STANDARDS  Female  Guidelines  Hospitals/*STANDARDS
       Human  HIV Seropositivity/DIAGNOSIS  *HIV Seroprevalence  Male
       Population Surveillance/METHODS  Risk Management  *Seroepidemiologic
       Methods  United States  GUIDELINE  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

